Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase‐based therapy
Hassan Sibai(Princess Margaret Cancer Centre), Jack T Seki(University Health Network), Joseph Brandwein(Goethe University Frankfurt), Tracy Murphy(University Health Network), Aaron D. Schimmer(University of Toronto), Arjun Law(University of Toronto), Karen Yee(University Health Network), Eshetu G. Atenafu(Princess Margaret Cancer Centre), Steven M. Chan(Princess Margaret Cancer Centre), Vikas Gupta(Indian Institute of Technology Kanpur), Umberto Falcone(University Health Network), Dawn Maze(University Health Network), Xing Liu(University of Science and Technology of China), Ruiqi Chen(University Health Network), Naoko Sakurai(University Health Network), Andre C. Schuh(University of Toronto), Caroline McNamara(University Health Network), Mark D. Minden(University Health Network)
Cited by 25
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2011|692
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
|Blood|2013|632
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|616